# 4 Active Controlled

**Page range:** 19â€“19

```text
4. Active Controlled
GP43164
A Phase 1, Two-arm, Open-label Study to
Evaluate the Clinical Drug-Drug Interaction
Potential of Pralsetinib in Combination with
Sensitive Transporter Substrates, Sensitive
CYP Substrates, or a Combined Oral
Contraceptive in Patients with Advanced or
Metastatic Solid Tumors that are not
Responsive to Standard Therapies or for
which there is no Effective Therapy
Phase I
```